KCNQ3 activation by the naturally occurring phenol, eugenol
Canadian Journal of Physiology and Pharmacology · 01.10.2025 · 103 (10) · 325-333
DOI: 10.1139/cjpp-2025-0064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, erschienen am 01.10.2025. Verfasst von Adrián Rivera-Ruedas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México. Hauptthemen laut MEDLINE: Eugenol, KCNQ3 Potassium Channel. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PAPIIT, UNAM.
Abstract (Originalsprache)
Pharmacological targeting of ion channels represents a crucial avenue for pain management. The KCNQ family of ion channels plays a significant role in controlling neuronal excitability and the generation and propagation of pain-related nerve impulses, mitigating excessive electrical signaling and limiting the transmission of pain signals. Eugenol has a variety of biological activities, including analgesic and anti-inflammatory properties. When used in conjunction with the anti-inflammatory drug diclofenac, eugenol demonstrates enhanced analgesic efficacy in animal models. We investigated the effects of eugenol on KCNQ ion channels. Eugenol acts as a KCNQ2/3 activator, shifting the voltage dependency to negative potentials, most of the activation can be explained by the effect on the KCNQ3, molecular docking simulation and mutagenesis experiments suggest that the binding pocket of eugenol is located at the top of the voltage-sensing domain. We also show that eugenol is a weak activator of the TRPV1 channel yet inhibits the capsaicin and acidic pH-activated current. Diclofenac also inhibits the TRPV1 channel current. In cells co-expressing KCNQ2/3 and TRPV1, eugenol and diclofenac limit the extent of membrane depolarization. Altogether, we report a new target for eugenol that adds to its wide array of biological activities, including its role in modulating acute pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México.
- Facultad de Química, Universidad Autónoma de Querétaro, Santiago de Querétaro, México.
- Departamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, México.
ORCID-Profile: Juan J Romero-Tovar, Victor De la Rosa
Förderung
- PAPIIT
- UNAM
Zitieren
APA
Rivera-Ruedas, A., Medina-Vilchis, A., Romero-Tovar, J., Cristóbal-Mondragón, G., & la Rosa, V. D. (2025). KCNQ3 activation by the naturally occurring phenol, eugenol. Canadian Journal of Physiology and Pharmacology, 103(10), 325-333. https://doi.org/10.1139/cjpp-2025-0064
Vancouver
Rivera-Ruedas A, Medina-Vilchis A, Romero-Tovar J, Cristóbal-Mondragón G, la Rosa VD. KCNQ3 activation by the naturally occurring phenol, eugenol. Canadian Journal of Physiology and Pharmacology. 2025;103(10):325-333. doi:10.1139/cjpp-2025-0064
BibTeX
@article{RiveraRuedas2025,
author = {Rivera-Ruedas, Adrián and Medina-Vilchis, Alejandro R and Romero-Tovar, Juan J and Cristóbal-Mondragón, Gema R and la Rosa, Victor De},
title = {KCNQ3 activation by the naturally occurring phenol, eugenol},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2025},
volume = {103},
number = {10},
pages = {325--333},
doi = {10.1139/cjpp-2025-0064}
}
EUVIMED